Publikasi Scopus Covid-19 Per 15 Juni 2023 (346 artikel)

Koesnoe, Sukamto (26028015000); Maria, Suzy (57213345044); Widhani, Alvina (57202561455); Hasibuan, Anshari S. (57219419129); Karjadi, Teguh H. (57219422563); Khoirunnisa, Dhiya (58078961000); Yusuf, Muhammad (58078457900); Sumariyono, Sumariyono (5747785
Koesnoe S.; Maria S.; Widhani A.; Hasibuan A.S.; Karjadi T.H.; Khoirunnisa D.; Yusuf M.; Sumariyono S.; Liastuti L.D.; Djauzi S.; Rengganis I.; Yunihastuti E.
COVID-19 vaccine provocation test outcome in high-risk allergic patients: A retrospective study from a tertiary hospital in Indonesia
World Allergy Organization Journal
Background: High COVID-19 vaccine coverage is essential. Patients who are considered high risk for hypersensitivity reactions and have had an allergic reaction to the COVID-19 vaccine are usually referred to an allergist for assessment of vaccination. Adm
Allergy; Anaphylaxis; COVID-19; Provocation test; Vaccination
S. Koesnoe; Division of Allergy and Clinical Immunology, Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Dr. Cipto Mangunkusumo Hospital, Jakarta, Jl. Diponegoro No. 71, 10430, Indonesia; email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Elsevier Inc.
19394551
World Allergy Organ. J.
Koesnoe S., Division of Allergy and Clinical Immunology, Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Maria S., Division of Allergy and Clinical Immunology, Department
Division of Allergy and Clinical Immunology, Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia
26028015000; 57213345044; 57202561455; 57219419129; 57219422563; 58078961000; 58078457900; 57477855200; 57204676441; 23495847800; 8449988000; 57221273925
0
2023
Article